Lledó Belén, Ten Jorge, Rodriguez-Arnedo Dori, Llácer Joaquín, Bernabeu Rafael
Department of Molecular Biology, Infertility Centre, Instituto Bernabeu, Alicante 03016, Spain.
Reprod Biomed Online. 2008 Jun;16(6):886-92. doi: 10.1016/s1472-6483(10)60157-5.
The aim of this study was to perform preimplantation genetic diagnosis (PGD) for X-linked retinoschisis using multiple displacement amplification (MDA) for whole genome amplification and linked markers to the RS1 gene. The study evaluates the ability of MDA to amplify the whole genome directly from a single blastomere. MDA products were used for polymerase chain reaction analysis of two polymorphic markers flanking the RS1 gene and a new X/Y marker, X22, to sex embryos in an X-linked retinoschisis PGD programme. Two couples in whom the wives were carriers of the RS1 gene mutation (599G-->A), previously identified in their families, were subjected to two PGD cycles each. The main outcome measure was the ability to analyse single blastomeres for X-linked retinoschisis using MDA. As a result, the development of an MDA-PGD protocol for X-linked retinoschisis allowed for the diagnosis of 20 embryos in the four PGD cycles performed. These were biopsied on day 3 of culture and analysed. Eight embryos were affected males and two embryos were female carriers. In summary, three healthy female and four healthy male embryos, and a female carrier embryo, were transferred 48 h after biopsy. One single pregnancy was achieved. This report shows that the MDA technique is useful for overcoming the problem of insufficient genomic DNA in PGD. It also allows the simultaneous amplification of different targets to perform diagnosis of any known gene defect and sexing test by standard methods and conditions.
本研究的目的是利用多重置换扩增(MDA)进行全基因组扩增,并结合与RS1基因相关的标记,对X连锁视网膜劈裂症进行植入前基因诊断(PGD)。该研究评估了MDA直接从单个卵裂球扩增全基因组的能力。MDA产物用于对RS1基因两侧的两个多态性标记以及一个新的X/Y标记X22进行聚合酶链反应分析,以便在X连锁视网膜劈裂症PGD程序中对胚胎进行性别鉴定。两对夫妇,妻子是其家族中先前已鉴定出的RS1基因突变(599G→A)的携带者,每对夫妇都接受了两个PGD周期。主要观察指标是使用MDA分析单个卵裂球是否患有X连锁视网膜劈裂症的能力。结果,针对X连锁视网膜劈裂症开发的MDA-PGD方案使得在进行的四个PGD周期中能够诊断20个胚胎。这些胚胎在培养第3天进行活检并分析。8个胚胎为受影响的男性,2个胚胎为女性携带者。总之,活检后48小时,移植了3个健康的女性胚胎、4个健康的男性胚胎和1个女性携带者胚胎。实现了一次单胎妊娠。本报告表明,MDA技术有助于克服PGD中基因组DNA不足的问题。它还允许同时扩增不同的靶标,以便通过标准方法和条件进行任何已知基因缺陷的诊断和性别鉴定测试。